| 9574006 |
Optimized anti-CD30 antibodies |
Gregory Alan Lazar, John Desjarlais, Philip W. Hammond, Bao-Lu Chen, Seung Chu +2 more |
2017-02-21 |
| 9040041 |
Modified FC molecules |
John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, John O. Richards, Gregory Moore |
2015-05-26 |
| 7973136 |
Optimized anti-CD30 antibodies |
Gregory Alan Lazar, John Desjarlais, Philip W. Hammond, Bao-Lu Chen, Seung Chu +2 more |
2011-07-05 |
| 7662367 |
Pharmaceutical compositions for the treatment of TNF-α related disorders |
John Desjarlais, Paul Michael Steed, Jonathan Zalevsky, David Szymkowski |
2010-02-16 |
| 6800732 |
Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
David C. Anderson, George P. Stricklin, Howard Welgus |
2004-10-05 |
| 6555322 |
&agr;2-macroglobulin receptor as a receptor for CTGF |
Patricia R. Segarini, James E. Nesbitt |
2003-04-29 |
| 6358741 |
Connective tissue growth factor (CTGF) and methods of use |
Brian Schmidt, Margaret Allen, Fran Sverdrup |
2002-03-19 |
| 6342374 |
Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
David C. Anderson, George P. Stricklin, Howard Welgus |
2002-01-29 |
| 6159460 |
Method for treating interleukin-1 mediated diseases |
Robert C. Thompson |
2000-12-12 |
| 6090585 |
Human collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
David C. Anderson, George P. Stricklin, Howard Welgus |
2000-07-18 |